After being fired, I became the light of medicine

Chapter 191 Simulation ends, new medicine!

Zhang Yang has never met Dr. Eric!
But Dr. Eric, who was tall and thin, wearing black round-frame glasses and a white Armani coat, made him feel deeply the tremendous pressure.

Especially when Dr. Eric's cold eyes swept across the open laptop and fell on his face, Zhang Yang felt an indescribable chill even more.

"I ask you again, why were you sitting in Evans's seat? Why did you touch his computer?"

"I……"

Zhang Yang was speechless. Countless excuses flashed through his mind, but none of them could explain why he was sitting here and why he opened Evans' laptop.

But just when he was in despair, a voice suddenly sounded:
"Doctor, why are you in the office?"

Zhang Yang was slightly shocked. Evans was back!
To be honest, even facing Dr. Eric's harsh questioning, he didn't feel much guilt, but...

At this moment, it was really difficult for him to face Evans!
Evans treated him as a friend, but he secretly opened Evans' laptop and peeked at the contents...

Evans also noticed Zhang Yang sitting in his seat and was a little confused, but the next second, he noticed that the laptop on his desk was turned on and had even entered the computer desktop.

This……

Evans looked at Zhang Yang in surprise, with a hint of disbelief in his eyes.

But after a moment, he looked at Dr. Eric beside him and seemed to understand something. He suddenly took a step forward and said to Zhang Yang:

"Zhang, have you found the information you need?"

After saying this, he calmly looked at Dr. Eric standing beside him and explained:
"Doctor, Zhang needed to look up some cell data just now, and it happened to be on my laptop, so I asked him to sit in my seat temporarily and use the laptop to look up the data."

After he finished speaking, Zhang Yang was stunned.

incredible!

Evans, Evans was actually lying for him and covering up for him!
Damn!

He suddenly looked up at Evans, with something indescribable in his eyes.

"Humph."

At this moment, Dr. Eric on the side snorted coldly, obviously very dissatisfied with this explanation.

After staring for two seconds, he said coldly:
"Evans, I've told you many times that no one can touch your laptop!"

"Have you forgotten?"

Evans lowered his head hastily and said apologetically:
"I'm sorry, Doctor. I had diarrhea and needed to go to the bathroom urgently, so..."

"Humph! I don't need your explanation. Pick up your notebook and follow me now. From today on, you will work somewhere else and you don't need to come here anymore."

"Okay, Doctor!"

After he finished speaking, Evans began to pack up his computer.

Zhang Yang just sat there motionless and watched. He looked at Evans. He wanted to speak but didn't know what to say!
He was unable to utter a word until Evans and Dr. Eric left the laboratory. Even his excitement over the discovery of the "T14 pneumonia virus" had dissipated a lot with Evans' actions just now.

"Evans..."

The departure of Evans and Dr. Eric allowed the laboratory to return to its usual tranquility, but Zhang Yang couldn't muster up any interest when looking at the 99% task progress on the task bar.

To be honest, at this moment he suddenly wanted to see Evans again and thank him in person.

Just like that, Zhang Yang was not in a hurry to complete the task. He silently waited for Evans to appear in the experiment, but Evans did not show up until the afternoon when it was almost time to get off work.

Unconsciously, the task progress on the task bar changed from 99% to 100%. At 6 pm, the picture gradually became blurred. Zhang Yang knew that the second stage of the task had been completed and was about to enter the settlement interface!

"It looks like I won't be able to meet Evans this time!"

"Forget it. I'll thank him in person the next time I meet him in the plot."

After he finished speaking, with a hint of regret, Zhang Yang exited the simulation and returned to the void. Then, a long list of rewards appeared before his eyes.

[“Pneumonia Virus”——The second phase of the plot simulation ends! ]

[Completion: 100%]

[This simulation score: A]

【Achievement outcome: Complete "T14-specific protein pathway analysis"】

[Evaluation: Specific proteins exist in all cells. They are powerful and not only control the communication and recognition between cells, but also participate in the transport and metabolism of nutrients in cells.]

[It can be said that specific proteins are an important part of normal cell survival and renewal. ]

[But in cancer cells, specific proteins are like the "black hands" hidden behind the disease. They also control the rapid division and proliferation of cells, allowing cancer cells to expand rapidly! ]

[Therefore, in the development of cancer targeted drugs, specific proteins often become precise targets for controlling cancer cells! ]

【Therefore, it is very important to analyze the specific proteins of cancer cells. Thank you for completing the "T14 specific protein" pathway analysis! 】

[This simulation has been completed effectively, you can check the ending. ]

[Reward: 500 energy points, currently a total of 900 energy points! ]

【Award: "Lung Cancer Solidification Ablative Agent" crystal form patent, synthesis route, and synthesis process. 】

【Award: Data analysis of pharmacokinetics, toxicokinetics, ethics, acute toxicity, and chronic toxicity of "lung cancer solidification ablation agent". 】

【Award: Complete Phase I and Phase II clinical data of "Lung Cancer Solidification Ablative Agent". 】

The energy value is 500 points, not bad.

However, “lung cancer solidifying ablation agent”?
Zhang Yang knew about ablation, which is a minimally invasive technique mainly used to treat early-stage cancer.

Simply put, it is to insert special electrodes or probes into tumor tissue and destroy cancer cells through high temperature or freezing.

The most mainstream treatment for lung cancer now is "radiofrequency ablation", also known as "radio frequency knife". It mainly involves inserting a "radio frequency electrode" into the tumor tissue, and then generating high temperatures inside the tumor cells through the electromagnetic field formed by high-frequency alternating current, thereby causing cancer cell necrosis and ultimately killing the cancer cells.

As for the other two types of "microwave ablation" and "cryoablation", they all follow the same principle, using probes to penetrate tumor tissue and destroy cancer cells through the "microwave principle" and "cryoablation principle".

In this way, ablation has many advantages. It does not require surgery, nor does it require the removal of a large amount of lung tissue that would cause harm to the patient.

But no matter what type of ablation, it has never been the first choice in the treatment of lung cancer!
The biggest reason is that cancer cells can easily spread to surrounding tissues, and ablation surgery can hardly completely eliminate all cancer cells.

In other words, ablation is prone to recurrence.

Thinking of this, Zhang Yang's eyes fell on the "Lung Cancer Solidifying Ablation Agent" rewarded by the system.

What kind of ablative is this?

After he slowly read the detailed introduction, he couldn't help but let out a sigh of relief.

Lung cancer solidification ablation agent:
The solidifying ablative agent can be injected into the tumor tissue through a bronchoscope or a special surgical probe.

After the solidifying ablative agent enters the lung tumor tissue, it will immediately release the drug ingredients, dehydrating all cell tissues within a 2 cm radius of the agent, and eventually solidifying the tumor tissue into a "lung fibrosis scab" with a radius of 2 cm, thereby eliminating the lung cancer lesions.

Special note: The dosage of this agent determines the size of the scab solidification, with a maximum radius of 3cm.

"good!"

Zhang Yang nodded.

Compared with traditional physical ablation methods such as radio frequency, microwave, and freezing, which are not thorough and prone to recurrence, the "lung cancer solidifying ablation agent" provided by the system is more like an indiscriminate elimination of all cells within a 3cm radius of the agent.

In this way, as long as the cancer cells are not too large, and are in the early or middle stages and have not spread widely, such as carcinoma in situ and microinvasion, this method can be used for solidification and ablation, and the effect should be good!

This method will undoubtedly greatly reduce the patient's pain, avoid lung resection surgery, and preserve lung function to the maximum extent!
Thinking of this, Zhang Yang immediately prepared to download the drug reward, but at this moment, another reward information suddenly flashed before his eyes.

[Congratulations to the host for completing the hidden reward - the bond of friendship! ]

[Reward: Research data on "T14 pneumonia virus" in Evans' laptop. ]

Hidden Rewards!

The bond of friendship!
T14 pneumonia virus research data? !
Evans!
Seeing the prompt, Zhang Yang's originally calm mood suddenly became excited.

He hurriedly clicked on the rewarded "T14 Pneumonia Virus" information, and after just one minute of reading, he was sure that this was the "T14 Pneumonia Virus" information he had seen in Evans' laptop before!

In an instant, Zhang Yang, who was originally interested in the "lung cancer solidification and ablation agent" rewarded by the system, lost interest in an instant, and immediately recalled the "T14 pneumonia virus" he had seen in the simulation plot before!

To be honest, he didn't get the answer he wanted in the previous simulation plot.

Although the "T14 pneumonia virus" has been confirmed, and although the "T14 pneumonia virus" can cause "lung adenocarcinoma" has also been confirmed,

But where did the pneumonia virus carrying the "T14-specific protein" come from?
Is it related to the Adrev biological laboratory?
Is it even said that it is related to AstraZeneca, which developed the third-generation targeted drug "Osimertinib"?

He doesn't know!
I was interrupted by Dr. Eric at the most critical moment!

but……

Now that I have calmed down, this matter is not important anymore!
Do not!
It should be said that since the simulation plot ended, it would be difficult for him to know the truth in a short period of time. The most important thing now is:

Find out whether the current lung adenocarcinoma cells carry the "T14-specific protein" that can lead to an increased incidence of lung adenocarcinoma in East Asians!
Also, among the currently prevalent pneumonia viruses, are there any pneumonia viruses that carry the "T14 specific protein"!

Thinking of this, Zhang Yang couldn't hold back any longer. He had to hurry up and verify these things in reality!
After quickly downloading the patent for "Lung Cancer Solidification and Ablation Agent" awarded by the system, and then downloading Evans' research data on "T14 Pneumonia Virus", Zhang Yang exited the simulator.

The next morning, he came to the office early and called Wei Tian, ​​the head of Qingshan Pharmaceutical's R&D center.

At this point, Zhang Yang no longer needs to hide his secrets. Currently, Qingshan Pharmaceutical's R&D investment and R&D capabilities are second to none in China, and even at the top level in the world.

Even the rapid introduction of some significant drugs would not arouse much suspicion.

As for Wei Tian, ​​Zhang Yang didn't have too many concerns.

Zhang Yang knew that he was a true genius in Wei Tian's eyes. In addition, the simulator's drug rewards were transmitted directly to the brain through brain waves. He was very familiar with all the patented technologies and drug mechanisms, so he was not afraid of being exposed even if he asked.

After making up a random excuse, Zhang Yang handed the patent information of "Lung Cancer Solidification and Ablation Agent" to Wei Tian, ​​and asked Wei Tian to apply for a patent and conduct animal experiments as soon as possible.

Wei Tian had no doubts.

While Wei Tian was beginning to apply for a patent for the "lung cancer solidification ablation agent" and was arranging animal experiments on the preparation, Zhang Yang devoted himself to the research of "T14-specific protein".

According to the plan, the first thing he had to determine was whether there was still "T2018 protein" in the "lung adenocarcinoma cells" from 14 to now.

Soon, Zhang Yang contacted Director Zhou of Chengdu Third People's Hospital!

Due to the traffic brought by the exclusive "nano-nodule contrast agent", even though "nodule contrast CT" can now be performed in many tertiary hospitals, the hospital still maintains the scale of 150-200 lung nodule surgeries per month.

Every lung nodule that is removed will undergo pathological testing, and naturally there will be a large amount of "lung adenocarcinoma cell tissue".

Zhang Yang briefly told Dean Zhou that he was researching lung adenocarcinoma and needed some lung adenocarcinoma tissue. He soon obtained nearly 200 of the latest "lung adenocarcinoma cell" sections.

Although Tsingshan Pharmaceutical does not have a professional virus laboratory, its cell laboratory is very complete.

Since a large number of lung adenocarcinoma cells carrying "T14-specific protein" had been analyzed in the simulation scenario before, Zhang Yang took charge of it personally and completed dozens of "lung adenocarcinoma cells" analyses in just two days.

As expected, 40 out of 21 lung adenocarcinoma cell tissues carried the "T14-specific protein" that can induce cancer.

In other words, these 21 "lung adenocarcinoma" patients most likely did not suffer from cancer caused by their own genes, smoking and other factors, but were infected with the "T14 pneumonia virus", which caused lung adenocarcinoma by the "T14 specific protein" in it!
but.

In addition to confirming the presence of "T14-specific protein" in current lung adenocarcinoma, Zhang Yang also noticed that many "T14-specific proteins" seemed to have undergone some mutations, which should be related to time.

It is normal for the virus to mutate in the few years from 2018 to now.

After confirming that the current "lung adenocarcinoma cells" do contain the same "T14-specific protein" as in the simulated plot, Zhang Yang immediately focused his research on the "T14 pneumonia virus."

Next, he wants to determine whether the pneumonia virus currently prevalent in reality carries the "T14 protein"!
But just as he was about to collect pneumonia strains, he suddenly encountered a thorny problem.

Do not,
It should be said that these are two tricky problems!
(End of this chapter)